Literature DB >> 2680973

Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.

T R Kozel1, M A Wilson, T P Farrell, S M Levitz.   

Abstract

Complement activation by Aspergillus fumigatus may play a crucial role in stimulating binding and killing of this organism by phagocytes. We examined the amount and type of C3 deposited on resting conidia, swollen conidia, and hyphae of A. fumigatus after incubation in pooled human serum. All three life forms of A. fumigatus were potent activators of the complement cascade, with deposition on the organisms of similar amounts of C3 per unit of surface area. The rate of deposition was slowest for resting conidia, although maximal deposition was still achieved within 40 min. The roles of the alternative and classical pathways were assessed by use of serum chelated with magnesium EGTA [magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid] and with an alternative pathway reconstituted from the six purified alternative-pathway proteins. Complement activation by resting conidia was mediated by the alternative pathway. In contrast, there was a progressive dependence on the classical pathway as the fungal particles matured into swollen conidia and then hyphae. Treatment with hydroxylamine, which disrupts ester linkages, removed 89 to 95% of the C3 bound to all three forms of A. fumigatus. This released C3 contained a mixture of C3b and iC3b, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. These data demonstrate that although all three forms of A. fumigatus are potent activators of the complement system, the transition from resting conidia to swollen conidia to hyphae results in progressive changes in the manner in which the fungal particles interact with the complement system. The lack of participation of the classical pathway in complement activation by resting conidia may have important implications regarding their ability to effectively stimulate phagocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680973      PMCID: PMC259839          DOI: 10.1128/iai.57.11.3412-3417.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  The C3b inactivator of the human complement system: homology with serine proteases.

Authors:  A E Davis
Journal:  FEBS Lett       Date:  1981-11-16       Impact factor: 4.124

3.  Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.

Authors:  M K Pangburn; D C Morrison; R D Schreiber; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

4.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

5.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

6.  The alternative pathway C3/C5 convertase: chemical basis of factor B activation.

Authors:  P H Lesavre; T E Hugli; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

7.  Inhibition of complement by culture supernatants of Aspergillus fumigatus.

Authors:  R G Washburn; C H Hammer; J E Bennett
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

8.  Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.

Authors:  T R Kozel; G S Pfrommer
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 9.  Aspergillosis.

Authors:  S M Levitz
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

Review 10.  C3 receptors on macrophages.

Authors:  S K Law
Journal:  J Cell Sci Suppl       Date:  1988
View more
  41 in total

1.  Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.

Authors:  J E Wang; A Warris; E A Ellingsen; P F Jørgensen; T H Flo; T Espevik; R Solberg; P E Verweij; A O Aasen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Deposition and degradation of C3 on type III group B streptococci.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia.

Authors:  V Annaix; J P Bouchara; G Larcher; D Chabasse; G Tronchin
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 4.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  A transcriptional signature accurately identifies Aspergillus Infection across healthy and immunosuppressed states.

Authors:  Julie M Steinbrink; Aimee K Zaas; Marisol Betancourt; Jennifer L Modliszewski; David L Corcoran; Micah T McClain
Journal:  Transl Res       Date:  2020-02-20       Impact factor: 7.012

6.  Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins.

Authors:  Rajashri Shende; Sarah Sze Wah Wong; Srikanth Rapole; Rémi Beau; Oumaima Ibrahim-Granet; Michel Monod; Karl-Heinz Gührs; Jayanta Kumar Pal; Jean-Paul Latgé; Taruna Madan; Vishukumar Aimanianda; Arvind Sahu
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

7.  Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils.

Authors:  L Christin; D R Wysong; T Meshulam; R Hastey; E R Simons; R D Diamond
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

8.  Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.

Authors:  R G Washburn; D J DeHart; D E Agwu; B J Bryant-Varela; N C Julian
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

9.  The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence.

Authors:  H F Tsai; Y C Chang; R G Washburn; M H Wheeler; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

10.  Role of ficolin-A and lectin complement pathway in the innate defense against pathogenic Aspergillus species.

Authors:  Stefan Bidula; Hany Kenawy; Youssif M Ali; Darren Sexton; Wilhelm J Schwaeble; Silke Schelenz
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.